Normal  ||| S:0 E:7 ||| JJ
and  ||| S:7 E:11 ||| CC
abnormal  ||| S:11 E:20 ||| JJ
human  ||| S:20 E:26 ||| JJ
skin  ||| S:26 E:31 ||| NN
color ||| S:31 E:36 ||| NN
:  ||| S:36 E:38 ||| :
from  ||| S:38 E:43 ||| IN
research  ||| S:43 E:52 ||| NN
to  ||| S:52 E:55 ||| TO
esthetics  ||| S:55 E:65 ||| VB
Skin  ||| S:65 E:70 ||| JJ
color  ||| S:70 E:76 ||| NN
is  ||| S:76 E:79 ||| VBZ
controlled  ||| S:79 E:90 ||| VBN
by  ||| S:90 E:93 ||| IN
pigmentary  ||| S:93 E:104 ||| JJ
genes  ||| S:104 E:110 ||| NNS
that  ||| S:110 E:115 ||| IN
regulate  ||| S:115 E:124 ||| JJ
constitutive  ||| S:124 E:137 ||| JJ
skin  ||| S:137 E:142 ||| NN
pigmentation  ||| S:142 E:155 ||| NNS
and  ||| S:155 E:159 ||| CC
by  ||| S:159 E:162 ||| IN
environmental  ||| S:162 E:176 ||| JJ
factors ||| S:176 E:183 ||| NNS
,  ||| S:183 E:185 ||| ,
the  ||| S:185 E:189 ||| DT
most  ||| S:189 E:194 ||| RBS
obvious  ||| S:194 E:202 ||| JJ
of  ||| S:202 E:205 ||| IN
them  ||| S:205 E:210 ||| PRP
being  ||| S:210 E:216 ||| VBG
solar  ||| S:216 E:222 ||| JJ
U.V.  ||| S:222 E:227 ||| NN
At  ||| S:227 E:230 ||| IN
this  ||| S:230 E:235 ||| DT
time ||| S:235 E:239 ||| NN
,  ||| S:239 E:241 ||| ,
more  ||| S:241 E:246 ||| JJR
than  ||| S:246 E:251 ||| IN
130  ||| S:251 E:255 ||| CD
distinct  ||| S:255 E:264 ||| JJ
pigmentary  ||| S:264 E:275 ||| JJ
genes  ||| S:275 E:281 ||| NNS
are  ||| S:281 E:285 ||| VBP
known ||| S:285 E:290 ||| VBN
.  ||| S:290 E:292 ||| .
They  ||| S:292 E:297 ||| PRP
affect  ||| S:297 E:304 ||| VBP
embryogenesis  ||| S:304 E:318 ||| VBN
and  ||| S:318 E:322 ||| CC
survival  ||| S:322 E:331 ||| NN
of  ||| S:331 E:334 ||| IN
the  ||| S:334 E:338 ||| DT
melanocyte  ||| S:338 E:349 ||| JJ
system ||| S:349 E:355 ||| NN
,  ||| S:355 E:357 ||| ,
mélanosome  ||| S:357 E:368 ||| JJ
biogenesis ||| S:368 E:378 ||| NN
,  ||| S:378 E:380 ||| ,
melanogenesis ||| S:380 E:393 ||| NN
,  ||| S:393 E:395 ||| ,
mélanosome  ||| S:395 E:406 ||| JJ
transport  ||| S:406 E:416 ||| NN
and  ||| S:416 E:420 ||| CC
transfer ||| S:420 E:428 ||| NN
,  ||| S:428 E:430 ||| ,
eumelanins ||| S:430 E:440 ||| FW
/ ||| S:440 E:441 ||| FW
pheomelanins  ||| S:441 E:454 ||| FW
ratio  ||| S:454 E:460 ||| NN
and  ||| S:460 E:464 ||| CC
epidermal  ||| S:464 E:474 ||| JJ
mélanosome  ||| S:474 E:485 ||| JJ
turn-over  ||| S:485 E:495 ||| JJ
and  ||| S:495 E:499 ||| CC
elimination ||| S:499 E:510 ||| NN
.  ||| S:510 E:512 ||| .
The  ||| S:512 E:516 ||| DT
pigmentary  ||| S:516 E:527 ||| JJ
disorders  ||| S:527 E:537 ||| NNS
of  ||| S:537 E:540 ||| IN
the  ||| S:540 E:544 ||| DT
skin  ||| S:544 E:549 ||| NN
are  ||| S:549 E:553 ||| VBP
common  ||| S:553 E:560 ||| JJ
and  ||| S:560 E:564 ||| CC
represent  ||| S:564 E:574 ||| VB
an  ||| S:574 E:577 ||| DT
important  ||| S:577 E:587 ||| JJ
part  ||| S:587 E:592 ||| NN
of  ||| S:592 E:595 ||| IN
dermatologist  ||| S:595 E:609 ||| JJ
activity ||| S:609 E:617 ||| NN
.  ||| S:617 E:619 ||| .
They  ||| S:619 E:624 ||| PRP
concern  ||| S:624 E:632 ||| NN
at  ||| S:632 E:635 ||| IN
the  ||| S:635 E:639 ||| DT
same  ||| S:639 E:644 ||| JJ
time  ||| S:644 E:649 ||| NN
the  ||| S:649 E:653 ||| DT
general  ||| S:653 E:661 ||| JJ
dermatology  ||| S:661 E:673 ||| NN
and  ||| S:673 E:677 ||| CC
the  ||| S:677 E:681 ||| DT
aesthetic  ||| S:681 E:691 ||| JJ
dermatology ||| S:691 E:702 ||| NN
.  ||| S:702 E:704 ||| .
